MCC
DNA icon

Money Concepts Capital’s Ginkgo Bioworks DNA Stock Holding History

Money Concepts Capital’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-139
Closed -$9.39K – 1075
2022
Q4 		$9.39K Buy
+139
New +$12.8K ﹤0.01% 2041
2022
Q2 		– Sell
-38
Closed -$6K – 1716
2022
Q1 		$6K Buy
+38
New +$7.4K ﹤0.01% 2118

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Money Concepts Capital's DNA Position: Q1 2023 in Review

Money Concepts Capital sold out of Ginkgo Bioworks (DNA) in Q1 2023, closing a stake of 139 shares — an estimated $9.39K sold.

Money Concepts Capital first reported a position in DNA in Q1 2022 and held it in 2 quarters. The position peaked at $9.39K in Q4 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q1 2023.

  • Money Concepts Capital reported no remaining Ginkgo Bioworks position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 139 Ginkgo Bioworks shares in Q1 2023, an estimated $9.39K.
  • Money Concepts Capital first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Ginkgo Bioworks position peaked at $9.39K in Q4 2022.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.